Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults

Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults

Background: The study was aimed at comparative evaluation of seasonal influenza vaccine RIBSP versus commercial vaccine VAXIGRIP® for immunogenicity and safety in the course of clinical trial phase II on healthy volunteers aged 18–60 years. Methods: The trial involved 150 subjects in randomized 2:1...

Full description

Bibliographic Details
Main Authors: Gulbanu Sarsenbayeva, Yevgeniy Volgin, Markhabat Kassenov, Timur Issagulov, Nikolay Bogdanov, Abylay Sansyzbay, Marina Stukova, Zhanna Buzitskaya, Ilyas Кulmagambetov, Timur Davlyatshin, Berik Khairullin
Format: Article
Language:English
Published: Taylor & Francis Group 2018-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
influenza
immune responses
vaccine
phase ii trial
seasonal
safety
Online Access:http://dx.doi.org/10.1080/21645515.2017.1387345

Internet

http://dx.doi.org/10.1080/21645515.2017.1387345

Similar Items